"That status quo frequently involves pharmaceutical companies’ making minor changes to existing drugs to gain additional market exclusivity, which keeps prices high." - @ChuckGrassley and @SenBillCassidyhttps://www.nationalreview.com/2019/10/prescription-drug-pricing-reduction-act-bipartisan-plan-make-prescription-drugs-affordable/ …
"The trick is to rein in gimmicks and abuses while maintaining incentives for true innovation that advances science. There must be a system that facilitates breakthrough treatments, but it needs to be sustainable for patients and taxpayers." - @ChuckGrassley and @SenBillCassidy